chr7-140808351-CA-C

Variant summary

Our verdict is . The variant received -10 ACMG points: 0P and 10B. BP6_ModerateBA1

The NM_004333.6(BRAF):​c.609-290delT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.112 in 197,348 control chromosomes in the GnomAD database, including 234 homozygotes. Variant has been reported in ClinVar as Benign (★). The gene BRAF is included in the ClinGen Criteria Specification Registry.

Frequency

Genomes: 𝑓 0.20 ( 231 hom., cov: 21)
Exomes 𝑓: 0.089 ( 3 hom. )

Consequence

BRAF
NM_004333.6 intron

Scores

Not classified

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.618

Publications

1 publications found
Variant links:
Genes affected
BRAF (HGNC:1097): (B-Raf proto-oncogene, serine/threonine kinase) This gene encodes a protein belonging to the RAF family of serine/threonine protein kinases. This protein plays a role in regulating the MAP kinase/ERK signaling pathway, which affects cell division, differentiation, and secretion. Mutations in this gene, most commonly the V600E mutation, are the most frequently identified cancer-causing mutations in melanoma, and have been identified in various other cancers as well, including non-Hodgkin lymphoma, colorectal cancer, thyroid carcinoma, non-small cell lung carcinoma, hairy cell leukemia and adenocarcinoma of lung. Mutations in this gene are also associated with cardiofaciocutaneous, Noonan, and Costello syndromes, which exhibit overlapping phenotypes. A pseudogene of this gene has been identified on the X chromosome. [provided by RefSeq, Aug 2017]
BRAF Gene-Disease associations (from GenCC):
  • cardiofaciocutaneous syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • cardiofaciocutaneous syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P, Ambry Genetics, PanelApp Australia
  • LEOPARD syndrome 3
    Inheritance: AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, PanelApp Australia
  • Noonan syndrome 7
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P, Ambry Genetics, PanelApp Australia
  • large congenital melanocytic nevus
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
  • Noonan syndrome
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • Noonan syndrome with multiple lentigines
    Inheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: Orphanet, ClinGen
  • anaplastic astrocytoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • Costello syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_004333.6, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP6
Variant 7-140808351-CA-C is Benign according to our data. Variant chr7-140808351-CA-C is described in ClinVar as Benign. ClinVar VariationId is 1296352.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.264 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004333.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRAF
NM_001374258.1
MANE Plus Clinical
c.609-290delT
intron
N/ANP_001361187.1A0A2R8Y8E0
BRAF
NM_004333.6
MANE Select
c.609-290delT
intron
N/ANP_004324.2
BRAF
NM_001374244.1
c.609-290delT
intron
N/ANP_001361173.1A0A2U3TZI2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRAF
ENST00000644969.2
MANE Plus Clinical
c.609-290delT
intron
N/AENSP00000496776.1A0A2R8Y8E0
BRAF
ENST00000646891.2
MANE Select
c.609-290delT
intron
N/AENSP00000493543.1P15056
BRAF
ENST00000288602.11
TSL:1
c.609-290delT
intron
N/AENSP00000288602.7A0A2U3TZI2

Frequencies

GnomAD3 genomes
AF:
0.197
AC:
8286
AN:
42134
Hom.:
231
Cov.:
21
show subpopulations
Gnomad AFR
AF:
0.271
Gnomad AMI
AF:
0.242
Gnomad AMR
AF:
0.133
Gnomad ASJ
AF:
0.187
Gnomad EAS
AF:
0.0943
Gnomad SAS
AF:
0.187
Gnomad FIN
AF:
0.103
Gnomad MID
AF:
0.224
Gnomad NFE
AF:
0.167
Gnomad OTH
AF:
0.192
GnomAD2 exomes
AF:
0.0677
AC:
1554
AN:
22952
AF XY:
0.0629
show subpopulations
Gnomad AFR exome
AF:
0.0849
Gnomad AMR exome
AF:
0.0934
Gnomad ASJ exome
AF:
0.0394
Gnomad EAS exome
AF:
0.107
Gnomad FIN exome
AF:
0.0453
Gnomad NFE exome
AF:
0.0568
Gnomad OTH exome
AF:
0.0738
GnomAD4 exome
AF:
0.0892
AC:
13853
AN:
155228
Hom.:
3
Cov.:
0
AF XY:
0.0889
AC XY:
8113
AN XY:
91260
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0907
AC:
267
AN:
2944
American (AMR)
AF:
0.0796
AC:
599
AN:
7526
Ashkenazi Jewish (ASJ)
AF:
0.0624
AC:
265
AN:
4248
East Asian (EAS)
AF:
0.0781
AC:
392
AN:
5020
South Asian (SAS)
AF:
0.0817
AC:
2393
AN:
29302
European-Finnish (FIN)
AF:
0.0981
AC:
654
AN:
6670
Middle Eastern (MID)
AF:
0.0880
AC:
53
AN:
602
European-Non Finnish (NFE)
AF:
0.0934
AC:
8571
AN:
91810
Other (OTH)
AF:
0.0927
AC:
659
AN:
7106
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.357
Heterozygous variant carriers
0
772
1545
2317
3090
3862
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
56
112
168
224
280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.197
AC:
8285
AN:
42120
Hom.:
231
Cov.:
21
AF XY:
0.194
AC XY:
3817
AN XY:
19726
show subpopulations
African (AFR)
AF:
0.271
AC:
3756
AN:
13856
American (AMR)
AF:
0.133
AC:
433
AN:
3264
Ashkenazi Jewish (ASJ)
AF:
0.187
AC:
234
AN:
1250
East Asian (EAS)
AF:
0.0938
AC:
119
AN:
1268
South Asian (SAS)
AF:
0.189
AC:
256
AN:
1358
European-Finnish (FIN)
AF:
0.103
AC:
130
AN:
1268
Middle Eastern (MID)
AF:
0.234
AC:
22
AN:
94
European-Non Finnish (NFE)
AF:
0.167
AC:
3168
AN:
18956
Other (OTH)
AF:
0.190
AC:
104
AN:
546
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
279
557
836
1114
1393
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
88
176
264
352
440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
-0.62
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.